treatment
In conclusion, GLP-1 treatment may        be considered in patients with diabetes mellitus secondary to chronic       pancreatitis, provided that a certain amount of alpha- and beta-cell secretory       capacity is still present.
In conclusion, GLP-1  @SUBJECT$  may        be considered  @PREDICAT$   @OBJECT$  with diabetes mellitus secondary to chronic       pancreatitis, provided that a certain amount of alpha- and beta-cell secretory       capacity is still present.